The involvement of p53 in pancreatic -cells mitophagy dysregulation offers additional evidence linking cancer, inflammation, and diabetes, in addition to its function as a tumour suppressor but also a controller of redox or glucose metabolism (Mathews et al., 2005). Here, TP53 is linked to diabetes mellitus.